Literature DB >> 12201821

Genetics of type 2 diabetes and insulin resistance: knowledge from human studies.

E A McIntyre1, M Walker.   

Abstract

Both type 2 diabetes mellitus (T2DM) and insulin resistance are complex traits in which multiple gene effects and metabolic and environmental factors combine to contribute to the overall pathogenesis of these conditions. This complexity has complicated the search for susceptibility genes and has led to different but complementary approaches being used for the detection of gene effects. These include the study of monogenic cases of insulin resistance and T2DM, association studies of candidate genes and genome-wide scans. The peroxisome proliferator-activated receptor gamma (PPARgamma) and calpain-10 (CAPN10) genes have recently been identified as T2DM susceptibility genes, and the lessons learnt from these studies are helping to shape future strategies to search for additional susceptibility genes in T2DM and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201821     DOI: 10.1046/j.1365-2265.2002.01610.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Type 2 diabetes mellitus in children and adolescents.

Authors:  M Marcovecchio; A Mohn; F Chiarelli
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Haplotype association of calpain 10 gene variants with type 2 diabetes mellitus in an Irish sample.

Authors:  F Alsaraj; D O'Gorman; S McAteer; J McDermott; Z Hawi; S Sreenan
Journal:  Ir J Med Sci       Date:  2010-02-02       Impact factor: 1.568

Review 3.  Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.

Authors:  Michelle A Vincent; Monica Montagnani; Michael J Quon
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

4.  Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways.

Authors:  Jane Palsgaard; Charlotte Brøns; Martin Friedrichsen; Helena Dominguez; Maja Jensen; Heidi Storgaard; Camilla Spohr; Christian Torp-Pedersen; Rehannah Borup; Pierre De Meyts; Allan Vaag
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

Review 5.  The genetics and pathophysiology of diabetes mellitus type II.

Authors:  A B Jenkins; L V Campbell
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 6.  Genetic and environmental aspect of polycystic ovary syndrome.

Authors:  E Carmina
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

7.  The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach.

Authors:  Hongfang Lu; Ying Yang; Emma M Allister; Nadeeja Wijesekara; Michael B Wheeler
Journal:  Mol Cell Proteomics       Date:  2008-04-30       Impact factor: 5.911

8.  Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes.

Authors:  Y Anis; O Leshem; H Reuveni; I Wexler; R Ben Sasson; B Yahalom; M Laster; I Raz; S Ben Sasson; E Shafrir; E Ziv
Journal:  Diabetologia       Date:  2004-07-03       Impact factor: 10.122

9.  Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome.

Authors:  Sonya J Elder; Alice H Lichtenstein; Anastassios G Pittas; Susan B Roberts; Paul J Fuss; Andrew S Greenberg; Megan A McCrory; Thomas J Bouchard; Edward Saltzman; Michael C Neale
Journal:  J Lipid Res       Date:  2009-04-16       Impact factor: 5.922

Review 10.  Emerging strategies and applications of pharmacogenomics.

Authors:  Patrice M Milos; Albert B Seymour
Journal:  Hum Genomics       Date:  2004-11       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.